Skip to main content

Table 2 Early subjects with an immediate treatment of acute HIV-1 infection.

From: Timely HAART initiation may pave the way for a better viral control

ID

Therapy†

Elapsed days ‡

Days on therapy

Days out therapy

At diagnosis*

At first interruption

     

CD4

CD8

vRNA

CD4

CD8

vRNA

Pt 03

D4T,3TC,IDV

14

1775

27

653

1659

75

809

459

5794

Pt 05

AZT,3TC,IDV

61

1657

27

444

633

100

867

476

< 50

Pt 29

AZT,3TC,NFV

14

1069

28

1103

1964

31

741

844

< 50

Pt 33

AZT,3TC,IDV

66

925

28

424

991

0.13

458

474

147

Pt 35

AZT,3TC,EFV

1

1041

30

522

1205

78

919

607

496

Pt 37

AZT,3TC,EFV

0

1371

790

545

1233

3.9

901

384

< 50

Pt 58

AZT,3TC,EFV

3

442

27

768

1632

50

1451

1580

< 50

Pt 06

AZT,3TC,IDV

32

1620

1908

882

4146

4.1

754

726

< 50

Pt 18

AZT,3TC,IDV

26

635

213

1319

1810

15

1718

825

< 80

Pt 24

AZT,3TC,IDV

3

1231

542

507

3162

78

513

1067

< 50

Pt 31

AZT,3TC,EFV

19

1102

1654

322

243

490

1154

1165

< 50

Pt 41

AZT,3TC,EFV

12

705

1837

568

278

130

1326

940

< 50

Pt 45

AZT,3TC,EFV

5

488

55

307

1032

130

872

506

< 50

Pt 53

AZT,3TC,Lop/rit

16

503

179

341

779

18.9

545

529

150

Pt 04

AZT,3TC,IDV

6

1561

2155

603

1288

1.6

1047

1015

88

Pt 19

AZT,3TC,IDV

13

1480

1640

1338

716

10

1113

447

< 50

Pt 28

AZT,3TC,NFV

7

325

70

281

860

190

863

485

< 80

Pt 32

AZT,3TC,EFV

15

1384

669

409

1448

4.3

960

331

< 50

Pt 72

AZT,3TC,LPV

7

318

343

827

386

19

1005

751

< 50

Pt 81

AZT,3TC,NVP

33

745

317

412

264

32.5

522

461

68

Pt 85

AZT,3TC,Lop/rit

46

717

717

326

669

50

855

1436

< 50

Pt 92

3TC,Lop/rit,TNF

0

455

331

616

3774

46.3

1027

913

< 50

  1. Clinical information about the twenty-two patients selected at the Clinical Department of the National Institute for Infectious Disease "L. Spallanzani" in Rome. All subjects received HAART within six months from primary infection.
  2. †D4T, staduvine; 3TC, lamivudine; IDV, Indinavir; AZT, Zidovudine; NFV, nelflnavir; EFV, Efavirenz; NVP, nevirapine; TNF, Tenofovir; Lop, lopinavir; Rit, Ritonavir; LPV (KAL), Kaletra (lopinavir/ritonavir). ‡ Days elapsed from diagnosis (enrollment) to initiation of HAART. *CD4 and CD8 are per microlitre of plasma, viremia is per millilitre of plasma.